{
  "metadata": {
    "version": "1.0.0",
    "analysis_type": "tumor_only",
    "genome_build": "GRCh38",
    "annotation_date": "2025-06-16"
  },
  "variants": [
    {
      "variant": {
        "chromosome": "7",
        "position": 140753336,
        "reference": "A",
        "alternate": "T",
        "gene": "BRAF"
      },
      "annotation": {
        "transcript": "ENST00000288602",
        "consequence": [
          "missense_variant"
        ],
        "protein_change": "p.Val600Glu",
        "coding_change": "c.1799T>A"
      },
      "evidence": [
        {
          "code": "OS1",
          "source": "OncoVI_Oncogenes",
          "score": 4,
          "description": "Potential activating variant in established oncogene BRAF"
        },
        {
          "code": "OM4",
          "source": "COSMIC_CGC",
          "score": 2,
          "description": "Mutation in gene with established role in cancer: oncogene, fusion"
        },
        {
          "code": "ONCOKB_LEVEL_1",
          "source": "OncoKB",
          "score": 0,
          "description": "FDA-approved therapy: Dabrafenib + Trametinib for BRAF V600E in all solid tumors (excluding colorectal cancer)"
        }
      ],
      "tiers": {
        "amp_tier": "Tier III",
        "vicc_oncogenicity": "Likely Oncogenic",
        "oncokb_level": "Level 1"
      },
      "confidence": 0.6372,
      "analysis_type": "TUMOR_ONLY"
    },
    {
      "variant": {
        "chromosome": "17",
        "position": 7674220,
        "reference": "G",
        "alternate": "A",
        "gene": "TP53"
      },
      "annotation": {
        "transcript": "ENST00000269305",
        "consequence": [
          "missense_variant"
        ],
        "protein_change": "p.Arg248Gln",
        "coding_change": "c.743G>A"
      },
      "evidence": [
        {
          "code": "OS1",
          "source": "OncoVI_Oncogenes",
          "score": 4,
          "description": "Potential activating variant in established oncogene BRAF"
        },
        {
          "code": "OM4",
          "source": "COSMIC_CGC",
          "score": 2,
          "description": "Mutation in gene with established role in cancer: oncogene, fusion"
        },
        {
          "code": "ONCOKB_LEVEL_1",
          "source": "OncoKB",
          "score": 0,
          "description": "FDA-approved therapy: Dabrafenib + Trametinib for BRAF V600E in all solid tumors (excluding colorectal cancer)"
        }
      ],
      "tiers": {
        "amp_tier": "Tier IV",
        "vicc_oncogenicity": "Likely Oncogenic",
        "oncokb_level": null
      },
      "confidence": 0.45249999999999996,
      "analysis_type": "TUMOR_ONLY"
    }
  ]
}